Impingement Syndrome Market Research Report - Forecast Till 2027

Impingement Syndrome Market Information: By Types (Structural Impingement, Functional Impingement), By Diagnosis (Physical Examination, Imaging), By Treatment (Drug Treatment, Non-Pharmacological Treatment, Surgery), By End Users (Hospitals, Physical Therapists) - Forecast Till 2027

ID: MRFR/Pharma/2968-HCR | September, 2022 | Region : Global

Table of Contents

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope of Study:

2.3 Research Objective

2.4 Market Structure

3 Research Process

3.1 Primary Research

3.2 Secondary Research

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.3 Restraints

4.4 Opportunities

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Impingement Syndrome Market, by Type

6.1 Introduction

6.2 Structural Impingement

6.3 Functional Impingement

7 Global Impingement Syndrome Market, By Diagnosis

7.1 Physical Examination

7.2 Imaging

7.2.1 Ultrasonography

7.2.2 Arthrography

7.2.3 MRI

8 Global Impingement Syndrome Market, By Treatment

8.1 Introduction

8.2 Drug Treatment

8.2.1 Corticosteroid

8.2.2 Local Anesthetic

8.2.3 NSAIDs

8.2.4 Other

8.3 Non-Pharmacological Treatment

8.3.1 Joint Mobilization

8.3.2 Interferential Therapy

8.3.3 Acupuncture

8.3.4 Soft Tissue Therapy

8.3.5 Therapeutic Taping

8.3.6 Rotator Cuff Strengthening

8.3.7 Other

8.4 Surgery

8.4.1 Arthroscopic Surgery

8.4.2 Open Surgery

8.4.3 Others

9 Global Impingement Syndrome Market, by End User

9.1 Introduction

9.2 Hospitals,

9.3 Physical Therapists

9.4 Others

10 Global Impingement syndrome Market by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic Of Korea

10.4.5 Australia

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of Middle East & Africa

11 Competitive Landscape

11.1 Introduction

11.2 Market share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profile

12.1 ATOS Klinik Heidelberg GmbH & Co. KG.

12.1.1Overview

12.1.2Product/Business Segment Overview

12.1.3Financial Overview

12.1.4Key Development

12.2 DePuy Synthes

12.2.1Overview

12.2.2Product/Business Segment Overview

12.2.3Financial Overview

12.2.4Key Developments

12.3 Johnson & Johnson Services, Inc.

12.3.1Overview

12.3.2Product/Business Segment Overview

12.3.3Financial Overview

12.3.4Key Developments

12.4 Stryker Corporation

12.4.1Overview

12.4.2Product/Business Segment Overview

12.4.3Financial Overview

12.4.4Key Developments

12.5 Medtronic

12.5.1Overview

12.5.2Product/Business Segment Overview

12.5.3Financials Updates

12.5.4Key Developments

12.6 Smith & Nephew

12.6.1Overview

12.6.2Product/Business Segment Overview

12.6.3Financial Updates

12.6.4Key Developments

12.7 B. Braun Melsungen AG

12.7.1Overview

12.7.2Product/Business Segment Overview

12.7.3Financial Updates

12.7.4Key Developments

12.8 Abbott

12.8.1Overview

12.8.2Product/Business Segment Overview

12.8.3Financial Updates

12.8.4Key Developments

12.9 Immediate Media Company Ltd.

12.9.1Overview

12.9.2Product/Business Segment Overview

12.9.3Financial Updates

12.9.4Key Developments

13 MRFR Conclusion

13.1 Key Findings

13.1.1From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Tissue Engineering Industries

14 Appendix

List of Tables

TABLE 1 GLOBAL IMPINGEMENT SYNDROME MARKET, BY TYPE, 2020 - 2027 (USD MILLION)

TABLE 2 STRUCTURAL IMPINGEMENT FOR IMPINGEMENT SYNDROME MARKET, BY REGION, 2020 - 2027 (USD MILLION)

TABLE 3 FUNCTIONAL IMPINGEMENT FOR IMPINGEMENT SYNDROME MARKET, BY REGION 2020 - 2027 (USD MILLION)

TABLE 4 GLOBAL IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2020 - 2027 (USD MILLION) TABLE

TABLE 5 GLOBAL IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2020 - 2027 (USD MILLION)

TABLE 6 GLOBAL IMPINGEMENT SYNDROME MARKET, BY END USER, 2020 - 2027 (USD MILLION)

TABLE 7 GLOBAL IMPINGEMENT SYNDROME MARKET, BY REGION 2020 - 2027 (USD MILLION)

TABLE 8 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY COUNTRY 2020 - 2027 (USD MILLION)

TABLE 9 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY TYPE 2020 - 2027 (USD MILLION)

TABLE 10 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2020 - 2027 (USD MILLION) TABLE

TABLE 11 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2020 - 2027 (USD MILLION)

TABLE 12 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY END USER, 2020 - 2027 (USD MILLION)

TABLE 13 NORTH AMERICA IMPINGEMENT SYNDROME MARKET BY REGION 2020 - 2027 (USD MILLION

TABLE 14 EUROPE IMPINGEMENT SYNDROME MARKET BY COUNTRY 2020 - 2027 (USD MILLION)

TABLE 15 EUROPE IMPINGEMENT SYNDROME MARKET, BY TYPE 2020 - 2027 (USD MILLION)

TABLE 16 EUROPE IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2020 - 2027 (USD MILLION) TABLE

TABLE 17 EUROPE IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2020 - 2027 (USD MILLION)

TABLE 18 EUROPE IMPINGEMENT SYNDROME MARKET, BY END USER, 2020 - 2027 (USD MILLION)

TABLE 19 EUROPE IMPINGEMENT SYNDROME MARKET, BY REGION 2020 - 2027 (USD MILLION)

TABLE 20 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY COUNTRY 2020 - 2027 (USD MILLION)

TABLE 21 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY TYPE 2020 - 2027 (USD MILLION)

TABLE 22 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2020 - 2027 (USD MILLION) TABLE

TABLE 23 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2020 - 2027 (USD MILLION)

TABLE 24 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY END USER, 2020 - 2027 (USD MILLION)

TABLE 25 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY REGION 2020 - 2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION 2020 - 2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY TYPE 2020 - 2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2020 - 2027 (USD MILLION) TABLE

TABLE 29 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2020 - 2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY END USER, 2020 - 2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION 2020 - 2027 (USD MILLION)

 

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET DYNAMICS FOR GLOBAL IMPINGEMENT SYNDROME MARKET

FIGURE 3 ATTRITION RATE OF PHASE III CLINICAL TRIALS IN EUROPE, 2020

FIGURE 4 IMPINGEMENT SYNDROME SUCCESS RATES IN VARIOUS PHASES OF CLINICAL TRIALS

FIGURE 5 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY TYPE 2020

FIGURE 6 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY DAIGNOSIS, 2020

FIGURE 7 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY TREATMENT, 2020

FIGURE 8 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY END USER, 2020

FIGURE 9 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY REGION, 2020

FIGURE 10 NORTH AMERICA IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2020

FIGURE 11 EUROPE IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2020

FIGURE 12 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2020

FIGURE 13 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION, 2020

FIGURE 14 GLOBAL IMPINGEMENT SYNDROME MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: KEY FINANCIALS

FIGURE 16 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: SEGMENTAL REVENUE

FIGURE 17 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: GEOGRAPHICAL REVENUE

FIGURE 18 DEPUY SYNTHES. KEY FINANCIALS

FIGURE 19 DEPUY SYNTHES. SEGMENTAL REVENUE

FIGURE 20 DEPUY SYNTHES: GEOGRAPHICAL REVENUE

FIGURE 21 JOHNSON & JOHNSON SERVICES, INC.: KEY FINANCIALS

FIGURE 22 JOHNSON & JOHNSON SERVICES, INC.: SEGMENTAL REVENUE

FIGURE 23 JOHNSON & JOHNSON SERVICES, INC.: GEOGRAPHICAL REVENUE

FIGURE 24 STRYKER CORPORATION. KEY FINANCIALS

FIGURE 25 STRYKER CORPORATION. SEGMENTAL REVENUE

FIGURE 26 STRYKER CORPORATION: GEOGRAPHICAL REVENUE

FIGURE 27 MEDTRONIC: FINANCIAL REVENUE

FIGURE 28 MEDTRONIC: SEGMENTAL REVENUE

FIGURE 29 MEDTRONIC: GEOGRPAHICAL REVENUE

FIGURE 30 SMITH & NEPHEW: FINANCIAL REVENUE

FIGURE 31 SMITH & NEPHEW: SEGMENTAL REVENUE

FIGURE 32 SMITH & NEPHEW: GEOGRPAHICAL REVENUE

FIGURE 33 B. BRAUN MELSUNGEN AG: FINANCIAL REVENUE

FIGURE 34 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 35 B. BRAUN MELSUNGEN AG: GEOGRPAHICAL REVENUE

FIGURE 36 ABBOTT: FINANCIAL REVENUE

FIGURE 37 ABBOTT: SEGMENTAL REVENUE

FIGURE 38 ABBOTT: GEOGRPAHICAL REVENUE

Impingement Syndrome Market Speak to Analyst Request a Free Sample